The largest database of trusted experimental protocols

5 protocols using sox2 creer

1

Inducible Cre-mediated Lineage Tracing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sox2-CreER; ROSA26-lox-stop-lox-EYFP mice were recreated from commercially available strains (Sox2-CreER: 017593; R26-lsl-EYFP: 006148) sold by the Jackson Laboratory (Bar Harbor, ME) [27 (link)]. To induce Cre-mediated activity, mice were administered 2 mg tamoxifen (TAM; Sigma, St. Louis, MO) suspended in corn oil by intraperitoneal injection daily for 4 consecutive days. For in utero lineage tracing, a single pulse of 2 mg TAM with 1 mg progesterone (Sigma) was given to pregnant females at E11.5. All animal care and use was approved and monitored by the University of Chicago Institutional Animal Care and Use Committee.
+ Open protocol
+ Expand
2

Conditional Genetic Manipulation in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiments were carried out according to protocols approved by the Institutional Animal Care and Use Committee at Harvard Medical School. Mouse lines are described in published literatures and purchased from the Jackson Laboratory: ShhGFP-Cre (Jackson Laboratory stock no. 005622), Prrx1Cre (Jackson Laboratory stock no. 005584), Sox2CreER (Jackson Laboratory stock no. 017593), tdTMTtg/+(Rosa26-TdTomato; Jackson Laboratory stock no. 007909), Tazf/f/Yapf/f (Jackson Laboratory stock no. 030532), conditional Yap* or Yapgof (Rosa26lox-stop-lox-rtTA/+;
Col1a1Teto-YapS127A/+) (38 (link)), Ptch1LacZ (53 (link)), and Ctgf-GFP (38 (link)). Timed mating of heterozygous intercrosses was performed to generate embryos of the indicated embryonic stage. The day in which a vaginal plug was confirmed was designated as E0.5. Mutant and transgenic embryos were processed in parallel with littermate controls. For the ShhCre;Yap* embryos, Dox was administered to pregnant female mice at 0.2 mg/ml in drinking water starting at E8.5. For Sox2CreER;Yap* embryos, Dox (same as above) and TM were administered at E7.5 (via intraperitoneal injection of the pregnant females (75 mg/kg of body weight).
+ Open protocol
+ Expand
3

Genetic Labeling of Diverse Cell Lineages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lgr5-EGFP-IRES-CreER (no. 008875) (Barker et al., 2007 (link)), Plp1-CreER (no. 005975) (Doerflinger et al., 2003 (link)), Sox2-CreER (no. 017593) (Arnold et al., 2011 (link)), and Rosa26-ACTB-mTmG (no. 007676) (Muzumdar et al., 2007 (link)) were obtained from the Jackson Laboratory. Rosa26-CAG-STOP-Cas9-tdTomato (Rosa26-tdTomato) mice were obtained from GemPharmatech, China. Pou4f3-EGFP-IRES-CreER or Pou4f3(EGFP/+) knockin mice were generated using the CRISPR-Cas9 genome-editing technology (Du et al., 2020 (link); Zhu et al., 2020 (link)). Both male and female mice on a C57BL6 background were used in this study. All animal procedures were approved by the Institutional Animal Care and Use Committee of Model Animal Research Center of Nanjing University, China, with protocol approval no. WGQ01.
+ Open protocol
+ Expand
4

Transgenic Mouse Models for Lineage Tracing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sox2-CreER, Math1-GFP, Lgr5-EGFP-IRES-CreER (referred as Lgr5-GFP), Stat3flox/flox, and Notch1flox/flox mice were purchased from Jackson laboratory. For Cre activation, 100 μL tamoxifen (10 mg/mL, Sigma) was administered to pregnant mice via gavage. 4-OH tamoxifen (100 mg/L, Sigma) was added into medium to induce Cre activity in vitro. All mouse experiments were approved by the Institutional Animal Care and Use Committee at the School of Biomedical Engineering, Shanghai Jiao Tong University.
+ Open protocol
+ Expand
5

Inducible Neurogenesis and Cancer Modeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rosa26-LSL-MYC (Stock no. 020458), Rosa26-LSL-tdTomato (Stock no. 007908), Math1-creER (Stock no. 007684), Ascl1-creER (Stock no. 012882), and Sox2-creER (Stock no. 017593) were purchased from the Jackson laboratory. CD1 mice were purchased from Charles River Laboratories. Mice were intraperitoneally injected with TMX (75 mg/kg) at E9.5, E10.5, E13.5, P0, P1, P2, P5, P7, or P9. Animals were sacrificed at E15.5, P4, P7, P10, P14, P21, P30, P75, or at a humane end point as they displayed signs of morbidity (ataxia, weight loss, and ruffled fur). Mice were housed in a certified animal facility in accordance with European Guidelines. The experiments were approved by the Italian Ministry of Health as conforming to the relevant regulatory standards.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!